Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$42.43 - $70.83 $140,019 - $233,739
3,300 Added 15.57%
24,500 $1.67 Million
Q2 2024

Aug 01, 2024

BUY
$41.33 - $74.26 $876,196 - $1.57 Million
21,200 New
21,200 $895,000
Q1 2023

May 08, 2023

SELL
$47.19 - $70.77 $4.22 Million - $6.33 Million
-89,500 Reduced 58.69%
63,000 $4.27 Million
Q3 2022

Nov 10, 2022

BUY
$31.97 - $49.37 $732,113 - $1.13 Million
22,900 Added 17.67%
152,500 $4.95 Million
Q2 2022

Aug 03, 2022

BUY
$35.61 - $76.23 $2.38 Million - $5.1 Million
66,900 Added 106.7%
129,600 $5.1 Million
Q1 2022

May 04, 2022

BUY
$57.56 - $82.54 $3.03 Million - $4.35 Million
52,700 Added 527.0%
62,700 $4.38 Million
Q4 2021

Feb 09, 2022

BUY
$72.5 - $100.68 $507,500 - $704,760
7,000 Added 233.33%
10,000 $778,000
Q1 2020

May 13, 2020

SELL
$37.9 - $104.44 $1.11 Million - $3.07 Million
-29,400 Reduced 90.74%
3,000 $174,000
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $4.22 Million - $5.42 Million
-54,300 Reduced 62.63%
32,400 $3 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $4.02 Million - $5.45 Million
-44,500 Reduced 33.92%
86,700 $7.84 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $10.9 Million - $14.3 Million
121,500 Added 1252.58%
131,200 $15.5 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $4.12 Million - $6.42 Million
-66,500 Reduced 87.27%
9,700 $840,000
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $2.29 Million - $3.37 Million
40,800 Added 115.25%
76,200 $4.81 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $768,526 - $1.11 Million
-19,300 Reduced 35.28%
35,400 $1.43 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $6.55 Million - $8.52 Million
-140,800 Reduced 72.02%
54,700 $2.87 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $100,034 - $127,224
2,700 Added 1.4%
195,500 $9.21 Million
Q2 2017

Aug 14, 2017

BUY
N/A
192,800
192,800 $6.82 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.